Cassava Sciences Inc vs Marathon Digital Holdings Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Marathon Digital Holdings Inc trades at $11.45 (market cap $4.69B). The key difference: Marathon Digital Holdings Inc is far larger — about 88.3× Cassava Sciences Inc's market cap, and Marathon Digital Holdings Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | MARA | |
|---|---|---|
Market Cap | $53.14M | $4.69B |
Sector | Health | Technology |
52-Week High | $4.64 | $22.84 |
52-Week Low | $1.09 | $6.73 |
Enterprise Value | -$33.43M | $6.64B |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
MARA stock trades at $11.74, down 3.45% today, amid a bearish technical trend and negative earnings momentum with three consecutive quarterly misses. The company reported a net loss of $1.31B on $907M revenue in 2025, though analyst sentiment remains mixed with a 50% buy rating and $17.88 consensus price target. Recent news highlights MARA's pivot to AI infrastructure, including a Texas land acquisition adding 2 GW power capacity (GlobeNewsWire, July 9, 2026).
The outlook balances strategic growth in AI against persistent profitability challenges. Investment opportunity lies in the AI pivot potentially driving future revenue, but risks include high cash burn, negative margins, and execution uncertainty. The stock's current valuation multiples suggest discount, but sustained losses warrant caution for investors.
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →